… However, HPV vaccination dread, concerns about its safety, and associated adverse … on
the HPV vaccine implementation campaigns all over the world. Many developed countries have …

… . Cervical cancer in developing countries: effective screening and preventive strategies
with an application in Rwanda. Health Care Women Int 2014;35:1065–80.doi:10.1080/…

… countries that use these vaccination programs has increased each month. Millions of girls in
developing countries … -income countries could be a helpful roadmap for developing nations (…

… take decades to develop, this is the same time horizon in which we should expect to confirm
vaccine impact against cancer. Whilst one follow-up study of vaccine trial participants is …

… , while developing countries with lack of HPV vaccination and/or worse modalities of
screening programs still have a high level of adverse outcomes [87]. These discrepancies in …

… vaccination account for approximately 90% of HPV-attributable cancers worldwide. Other
HPV vaccines have been developed … women in Nordic countries who had been vaccinated in …

… Although more than 30% of females aged 10–20 years in developed countries … Development
Index (HDI) country with early and high coverage implementation of both HPV vaccination …

… Population-level impact and herd effects following the introduction of human papillomavirus
vaccination programmes: Updated systematic review and meta-analysis. Lancet 2019, 394, …

… countries.Less than 25% of low income countries have human papillomavirus vaccination as
… Most gaps in the introduction and coverage of human papillomavirus vaccine are in regions …

… , especially in developing countries. Three HPV … vaccination strategies in any country should
be temporarily postponed until all countries have been able to introduce HPV vaccination in …